The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Akorn Gets Warning Letter from FDA
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
pharmamanufacturing
April 2, 2007
Akorn Pharma's Decatur, Illinois plant has received a warning letter for GMP violations in the manufacture of its
IC-Green intravenous dye
.� Ouch.
About the Author
pharmamanufacturing
pharmamanufacturing
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
Editor’s (re)View: Trump’s on-again, off-again pharma tariffs are getting old
Sponsored
OnTrak Wireless: Total Bearing Health Solution
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Trending
CDMOs in China and US are forecast to see fastest growth: analysis
Lilly to invest $1.2B in Puerto Rico facility to boost US oral medicine manufacturing
Biopharma’s manufacturing agility wanes amid supply chain resilience: survey
Sponsored Picks
Sponsored
OnTrak Wireless: Total Bearing Health Solution
Sponsored
Early Intervention with OnTrak Wireless for High-Heat Environments
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Load More Content